Clinical Trial Update: Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the long-term effects of semaglutide on appetite and eating behavior in obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• WEGOVY (Semaglutide)

Snippet

Sponsor: University of Pennsylvania | Conditions: Obesity | Phase 4 | Status: COMPLETED